Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients

Journal of Hematotherapy and Stem Cell Research

Volumn 12, Issue 4, 2003, Pages 375-387

  Davis, Brian M ^a   Reese, Jane S ^a   Lingas, Karen ^a   Gerson, Stanton L ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; CARMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MUTANT PROTEIN; RETROVIRUS VECTOR;

ADOLESCENT; ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL LINEAGE; CELL POPULATION; CELL REPOPULATION; CELL SELECTION; CONTROLLED STUDY; DRUG RESISTANCE; EXPRESSION VECTOR; GENE EXPRESSION; GENE NUMBER; GENE SILENCING; GENE THERAPY; GENETIC SELECTION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; MFG RETROVIRUS VECTOR; MOUSE; MPSV RETROVIRUS VECTOR; MULTILINEAGE HEMATOPOIETIC STEM CELL; NONHUMAN; ONCOVIRINAE; PRIORITY JOURNAL; RECIPIENT; SF RETROVIRUS VECTOR; SPLEEN; THYMUS; TRANSGENE; VIRUS RECOMBINANT;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL LINE; CELL LINEAGE; CELL SEPARATION; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE SILENCING; GENETIC VECTORS; GENOME; GUANINE; HEMATOPOIETIC STEM CELLS; HUMANS; K562 CELLS; MICE; MICE, INBRED C3H; MODELS, GENETIC; MUTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; RETROVIRIDAE PROTEINS, ONCOGENIC; STEM CELLS; TIME FACTORS; TRANSGENES;

EID: 0041522307     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581603322286015     Document Type: Article

References (23)

1. Davis B, O Koc and S Gerson. (2000). Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferse-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood 95:3078-3084.
2. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 57:5093-5099.
3. Byun J, S Kim, J Kim, S Yu, P Robbins, J Yim and S Kim. (1996). Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy. Gene Ther 3:780-788.
4. Baum C, S Hegewisch-Becker, H-G Eckert, C Stocking and W Ostertag. (1995). Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol 69:7541-7547.
5. Krall W, D Skelton, X-J Yu, I Riviere, P Lehn, R Mulligan and D Kohn. (1996). Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther 3:37-48.
6. Riviere I, K Brose and R Mulligan. (1995). Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733-6737.
7. 6-benzylguanine plus BCNU. Proc Natl Acad Sci USA 93:14088-14093.
8. 6-alkylguanine DNA alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells. Clin Cancer Res 4:475-481.
9. Liu L, B Davis and S Gerson. (1999). MMR deficient colon cancer cells acquire BG-resistant mutations in AGT during treatment with BG plus BCNU. Proc Am Assoc Cancer Res 40:139a.
10. 6-benzylguanine and BCNU and allows intensive therapy of BCNU resistant human colon cancer xenografts. Human Gene Ther 10:1021-1030.
11. Ragg S, M Xu-Welliver, J Bailey, M D'Souza R Cooper, S Chandra, R Seshadri, AE Pegg and DA Williams. (2000). Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells. Cancer Res 60:5187-5195.
12. Boggs S, K Patrene, G Mueller, C Evans, L Doughty and P Robbins. (1995). Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA. Gene Ther 2:632-638.
13. Learish R, T Ohashi, P Robbins, A Bahnson, S Boggs, K Patrene, B Schwartz, V Gieselmann and J Barranger. (1996). Retroviral gene transfer and sustained expression of human arylsulfatase A. Gene Ther 3:343-349.
14. phox-deficient model of chronic granulomatous disease. Blood 89:2268-2275.
15. Cavazzana-Calvo M, S Hacein-Bey, G de Saint Basile, F Gross, E Yvon, P Nusbaum, F Selz, C Hue, S Certain, J Casanova, P Bousso, F Deist and A Fischer. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288:669-672.
16. - cells expanded in vitro: cis elements of FMEV are superior to those of Mo-MuLV. Hum Gene Ther 11:271-284.
17. Schiedlmeier B, K Kuhlcke, HG Eckert, C Baum, WJ Zeller and S Fruehauf. (2000). Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood 95:1237-1248.
18. Grez M, E Akgun, F Hilberg and W Ostertag. (1990). Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 87:9202-9206.
19. Hawley R, F Lieu, A Fong, and T Hawley. (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1:136-138.
20. Allay J, D Persons, J Galipeau, J Riberdy, R Ashmun, R Blakely and B Sorrentino. (1998). In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med 4:1136-1143.
21. Dinauer M, L Li, H Bjorgvinsdottir, C Ding and N Pech. (1999). Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease. Blood 94:914-922.
22. Robbins P, X Yu, D Skelton, K Pepper, R Wasserman, L Zhu and D Kohn. (1997). Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol 71:9466-9474.
23. Robbins P, D Skelton, X-J Yu, S Halene, E Leonard and D Kohn. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc Natl Acad Sci USA 95:10182-10187.